SAD/MAD of ABX-002-1902 Investigating the Safety, Pharmacokinetics/Pharmacodynamics of in Healthy Subjects

NCT05528315 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

MDD

Interventions

DRUG: ABX-002
DRUG: Placebo

Sponsor

Autobahn Therapeutics, Inc.

Collaborators

[object Object]